PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.070
-0.010 (-0.93%)
Jun 27, 2025, 4:00 PM - Market closed
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $55.59 million as of June 27, 2025. Its market cap has decreased by -37.54% in one year.
Market Cap
55.59M
Enterprise Value
-109.13M
1-Year Change
-37.54%
Ranking
Category
Stock Price
$1.07
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $55.59M, a decrease of -96.55%. That is a compound annual growth rate of -50.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 57.15M | -26.86% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | 2.75B | 70.75% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.51B |
| Johnson & Johnson | 365.82B |
| AbbVie | 329.86B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.46B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.39B |
| AstraZeneca | 216.45B |